Drug for treating muscular atrophy

A muscle atrophy and drug technology, applied in the field of medicine, to achieve the effect of improving self-immunity and good curative effect

Inactive Publication Date: 2015-07-01
吴旭
0 Cites 2 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0002] Clinically, due to the lack of exact understanding of the etiology and pathogenesis of muscle atrophy, there is no eff...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Abstract

The invention relates to the technical field of medicine, and particularly relates to a drug for treating muscular atrophy. The drug is composed of the components in parts by weight: 10-20 parts of angelica sinensis, 10-20 parts of pseudo-ginseng, 8-12 parts of radix bupleuri, 10-15 parts of medlar, 6-12 parts of antler, 11-15 parts of beautiful sweetgum fruit, 5-9 parts of asarum sieboldii, 8-10 parts of pericarpium citri reticulatae, 10-15 parts of radix salviae miltiorrhizae, and 10-18 parts of radix cyathulae. The invention aims to provide the drug for treating muscular atrophy, wherein the drug is good in curative effect and improves the human body immunity.

Application Domain

Technology Topic

Angelica tenuissimaPericarpium citri reticulatae +6

Examples

  • Experimental program(3)

Example Embodiment

[0008] Example 1, a medicine for the treatment of muscle atrophy, the material is composed of 15 parts by weight: Angelica sinensis 15 parts, Panax notoginseng 15 parts, Bupleurum 10 parts, Chinese wolfberry 12.5 parts, Antlers 9 parts, Passepartout 13 parts, fine 7 parts of Xin, 9 parts of dried tangerine peel, 12.5 parts of Salvia miltiorrhiza, and 14 parts of Achyranthes bidentata; the medicine is prepared into granules, capsules or decoctions according to conventional preparation techniques.

Example Embodiment

[0009] Example 2, a medicine for treating muscle atrophy, the materials are composed of 20 parts by weight: Angelica sinensis 20 parts, Panax notoginseng 20 parts, Bupleurum 12 parts, Lycium barbarum 15 parts, Antlers 12 parts, Passepartout 15 parts, Fine 9 parts of Xin, 10 parts of dried tangerine peel, 15 parts of Salvia miltiorrhiza, and 18 parts of Achyranthes bidentata; the medicine is prepared into granules, capsules or decoctions according to conventional preparation techniques.

Example Embodiment

[0010] Example 3, a medicine for the treatment of muscle atrophy, the material is composed of: 20 parts by weight of Angelica sinensis, 20 parts of Panax notoginseng, 12 parts of Bupleurum, 15 parts of Chinese wolfberry, 12 parts of antlers, 15 parts of Passepartout, thin 9 parts of Xin, 10 parts of dried tangerine peel, 15 parts of Salvia miltiorrhiza, and 18 parts of Achyranthes bidentata; the medicine is prepared into granules, capsules or decoctions according to conventional preparation techniques.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Similar technology patents

Classification and recommendation of technical efficacy words

  • Good curative effect
  • Improve autoimmunity

Portunus trituberculatus larva cultivation forage

ActiveCN103734490AIncrease irritabilityImprove autoimmunityAnimal feeding stuffPortunus trituberculatusSpirodela
Owner:山东中科能人工环境有限公司

Cold medicine

Owner:青岛丰泽中兴科技服务有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products